Industry News

Prothena Corporation plc, a late-stage clinical biotechnology company focused on the discovery, development, and commercialization of novel protein immunotherapies, today announced that members of its management team will discuss the Phase 2 development strategy for PRX003, the antibody in development for the potential treatment of inflammatory diseases, including psoriasis, during a webcast on September 29.. Conference Call and Webcast..."/>
Prothena to Host Update on PRX003 Phase 2 Development Strategy
Anika Therapeutics, Inc.,, a global, integrated orthopedics medicines company specializing in therapeutics based on its proprietary hyaluronic acid technology, today announced four data presentations on HYALOFAST, a biodegradable HA-based scaffold, at the 13 th World Congress of the International Cartilage Repair..."/>
Anika Announces Data Presentations on HYALOFAST Hyaluronic Acid-Based Scaffold at 2016 World Congress of the International Cartilage Repair Society
NeuroDerm Ltd., a clinical stage pharmaceutical company developing drugs for central nervous system disorders, today reported human factors data from a usability study focused on the interactions between Parkinson’ s disease patients and the mini-pump device used to administer ND0612, the Company’ s continuous, subcutaneously delivered levodopa/carbidopa liquid formulation. The data were presented today at the 4 th World Parkinson Congress,..."/>
NeuroDerm’s ND0612 Mini-Pump Delivery System Successfully Used by Parkinson’s Disease Patients in Home Setting
Tactile Systems Technology, Inc., a medical technology company that develops and provides innovative medical devices for the treatment of chronic diseases at home, announced today that it has received 510 clearance from the U.S. Food and Drug Administration for the Flexitouch System in treating lymphedema of the head and neck, a common consequence of head and neck cancer.. “This is a major milestone for our company and a first for the lymphedema..."/>
Tactile Medical Receives FDA 510(k) Clearance for New Indication of At-Home Lymphedema Treatment
Manitex Capital Inc. is pleased to announce that it has subscribed for and purchased unsecured convertible debentures of Cold Water Fisheries Inc. for an aggregate principal amount of $700,000. The Debentures have a maturity date of March 31, 2019 and the Principal Amount outstanding under the Debentures is convertible into common shares of CWF at the option of Manitex at any time prior to the Maturity Date. The conversion price is..."/>
Manitex Capital Inc. acquires convertible debentures of Cold Water Fisheries Inc. and provides advisory services on going-public transaction
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of moderate-to-severe acute pain, today announced that Dr. Shankar Lakshman, a board-certified plastic surgeon and AcelRx clinical investigator, will present a subgroup analysis from the SAP301 study at the annual meeting of the American Society of Plastic Surgeons."/>
Findings from AcelRx Pharmaceuticals' Phase 3 SAP301 Study of ARX-04 in Abdominoplasty Patients to be Presented at Plastic Surgery Meeting
Eleven Biotherapeutics, Inc. has acquired Canada-based protein therapeutic technology company Viventia Bio Inc, the company said. Under the agreement, Eleven purchased all of the outstanding capital stock of Viventia in exchange for the issuance of 4,013,431 newly issued shares of Eleven common stock. This represented approximately 19.9% of the voting power of Eleven as of immediately prior to the..."/>
Eleven Biotherapeutics Buys Protein Therapeutic Technology Firm Viventia Bio
Cigna and UnitedHealth-- announced they would be pulling out of the Texas marketplace."/>
As insurers pull out, Obamacare sign comes down in Fort Worth [Fort Worth Star-Telegram]
IIROC Trading Halt - I
Ardelyx, Inc., a clinical-stage biopharmaceutical company focused on gastrointestinal and cardio-renal diseases, today announced that Mark Kaufmann, Chief Financial Officer, will present an overview of the Company during the Ladenburg Thalmann 2016 Healthcare Conference at 9:30 a.m. Eastern Time on Tuesday, September 27, 2016 at the Sofitel New York Hotel in New York, NY. Paul Korner, MD, MBA, the Company's Executive Vice President and..."/>
Ardelyx to Present at Ladenburg Thalmann 2016 Healthcare Conference
Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced its partnership with the Royal Health Awareness Society of Jordan to advance health awareness and education particularly on thyroid disease amongst Jordanian women."/>
Merck KGaA, Darmstadt, Germany and the Royal Health Awareness Society Partner to Advance Women's Health in Jordan
Magellan Health, Inc. today announced that it will release third quarter 2016 earnings results on Wednesday, November 9, 2016. Management will discuss the company's financial results, as well as its business strategy and outlook, on a conference call to be held the same day from 9:00 a.m. to 10:00 a.m. Eastern. The press release detailing the company's third quarter 2016 earnings results will be issued at approximately 6:30 a.m. Eastern, and will be..."/>
Magellan Health Announces Third Quarter 2016 Earnings Conference Call
Retractable Technologies, Inc. announced today that its Board of Directors has declared dividends to holders of its Series I Class B and Series II Class B Convertible Preferred Stock in the amounts of $12,312.50 and $42,800.00, respectively. The dividend amount is $0.125 per share for Series I Class B shareholders and $0.25 per share for Series II Class B shareholders. Dividends have accrued at 10% per annum and cover amounts in arrears from and including July..."/>
Retractable Technologies, Inc. Declares Dividends to Series I and II Class B Preferred Stock Shareholders
Cigna to produce letters they have sent accusing each other of breaching an agreement in which Anthem would purchase Cigna. The federal antitrust regulators discovered the letters because Cigna's lawyer told an official on Aug. 16 that both its in-house attorney and Anthem's have "exchanged letters accusing each other of breaching the merger agreement." The next day, the DOJ, served Anthem and Cigna..."/>
Anthem, Cigna Accuse Each Other Of Breaching Merger Agreement [The Hartford Courant]
UnitedHealth Group will release its financial results for the third quarter of 2016 on Tuesday, October 18, 2016, before the market opens, and will host a teleconference at 8:45 a.m. ET to discuss the results with analysts and investors. This call will be webcast on the Investors page of the company's web site. The replay will be available on the web site or by dialing 1-800-283-4799 through November 1."/>
UnitedHealth Group Schedules Third Quarter Earnings Release and Conference Call for October 18, 2016
Genmab A/S. COPENHAGEN, Denmark, Sept. 22, 2016-- Genmab A/S announces under reference to Section 29 of the Danish Securities Trading Act that Baillie Gifford& Co has informed us that, as of September 22, 2016, Baillie Gifford& Co has increased their indirect ownership in Genmab A/S to 3,021,069 shares, which amounts to 5.02% of the share capital and voting rights in Genmab A/S.. About Genmab Genmab is a publicly traded, international biotechnology..."/>
Major Shareholder Announcement
SolarCity solar panel factory, IBM's data analytics center in Buffalo and the Albany Molecular Research Inc. drug development venture on the Buffalo Niagara Medical Campus, already have opened or are in advanced stages."/>
What the corruption charges will mean for the Buffalo Billion [The Buffalo News, N.Y.]
Pfizer Inc. today declared a 30- cent fourth-quarter 2016 dividend on the company’ s common stock, payable December 1, 2016, to shareholders of record at the close of business on November 11, 2016. The fourth-quarter 2016 cash dividend will be the 312 th consecutive quarterly dividend paid by Pfizer. At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives."/>
Pfizer Declares 30-Cent Fourth-Quarter 2016 Dividend

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Most Popular Sectors in the News
Sectors Articles in the last 7 days
Information Technology727 Articles
Consumer Discretionary615 Articles
Financials455 Articles
Industrials399 Articles
Health Care390 Articles

Sponsored Financial Commentaries

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact , please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at